Skip to main content

Table 3 End-point values for primary and secondary outcomes, adjusted for sex, baseline scores and baseline daily step count

From: The MIPAM trial: a 12-week intervention with motivational interviewing and physical activity monitoring to enhance the daily amount of physical activity in community-dwelling older adults – a study protocol for a randomized controlled trial

Characteristics

Control group (n=)

Intervention group (n=)

P

Primary outcome

Average daily step count, mean (95% CI)

Secondary outcomes

 EQ VAS, mean (95% CI)

 UCLA Loneliness Scale, mean n (%)

 OEE average score, mean (95% CI)

 SEE average score, mean (95% CI)

 IPAQ-SF MVPA, mean (95% CI)

 IPAQ-SF Walking time, mean (95% CI)

 IPAQ-SF Sedentary time, mean (95% CI)

 NPAQ MVPA, mean (95% CI)

  1. BMI: Body Mass Index, PAM: Physical Activity Monitor, EQ-5D: EuroQol Research Foundation Five Domains, UCLA: University of California Los Angeles, OEE: Outcome Expectancy for Exercise, SEE: Self Efficacy for Exercise. IPAQ-SF: International Physical Activity Questionnaire-Short Form, NPAQ: Nordic Physical Activity Questionnaire-Short Form, MVPA: Moderate to Vigorous Physical Activity, SD: standard deviation, 95% CI: 95% confidence intervals, IQR: interquartile range, between-group differences calculated from linear regression model, adjusted for baseline scores, sex and baseline daily step count, using imputed values from the Gaussian normal regression method (baseline step count, sex and age). p values for between group difference ≤.05 are considered significant